CAR T cells ignite antitumor immunity

Broadening immune responses through antigen spreading remains the ‘Holy Grail’ of cancer immunotherapy. A study by Ma and colleagues reveals that vaccine boosting of chimeric antigen receptor (CAR)-T cells in mice promotes endogenous immunity and elicits antigen spread to eliminate antigenically het...

Full description

Saved in:
Bibliographic Details
Published inTrends in immunology Vol. 44; no. 10; pp. 748 - 750
Main Authors Alizadeh, Darya, Brown, Christine E.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.10.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Broadening immune responses through antigen spreading remains the ‘Holy Grail’ of cancer immunotherapy. A study by Ma and colleagues reveals that vaccine boosting of chimeric antigen receptor (CAR)-T cells in mice promotes endogenous immunity and elicits antigen spread to eliminate antigenically heterogenous solid tumors through a mechanism crucially dependent on interferon (IFN)γ. Broadening immune responses through antigen spreading remains the ‘Holy Grail’ of cancer immunotherapy. A study by Ma and colleagues reveals that vaccine boosting of chimeric antigen receptor (CAR)-T cells in mice promotes endogenous immunity and elicits antigen spread to eliminate antigenically heterogenous solid tumors through a mechanism crucially dependent on interferon (IFN)γ.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1471-4906
1471-4981
DOI:10.1016/j.it.2023.08.002